(S)-(+)-N-(3,5-DINITROBENZOYL)-ALPHA-PHENYLGLYCINE
|
|
|
- CAS-Nr.
- 90761-62-9
- Englisch Name:
- (S)-(+)-N-(3,5-DINITROBENZOYL)-ALPHA-PHENYLGLYCINE
- Synonyma:
- D-3,5-Dinitrobenzoylleucine;L-3,5-Dinitrobenzoylphe nylglycine;n-(3,5-dinitrobenzoyl)-l-α-phenylglycine;N-(3 5-DINITROBENZOYL)-L-ALPHA-PHENYL- &;(S)-3,5-DINITRO-BENZOYL-L-PHENYL GLYCINE;(S)-(+)-N-(3,5-DINITROBENZOYL) PHENYLGLY;(S)-(+)-N-(3,5-DINITROBENZOYL)PHENYLGLYCINE;N-(3,5-DINITROBENZOYL)-L-ALPHA-PHENYLGLYCINE;METHYL 2,3-EPOXY-3-(4-METHOXYPHENYL)PROPRONATE;(S)-(+)-N-(3,5-Dinitrobenzoyl)-α-phenylglycine
- CBNumber:
- CB1108244
- Summenformel:
- C15H11N3O7
- Molgewicht:
- 345.27
- MOL-Datei:
- 90761-62-9.mol
|
(S)-(+)-N-(3,5-DINITROBENZOYL)-ALPHA-PHENYLGLYCINE Eigenschaften
- Schmelzpunkt:
- 218-220 °C(lit.)
- Siedepunkt:
- 569.4±50.0 °C(Predicted)
- Dichte
- 1.527±0.06 g/cm3(Predicted)
- storage temp.
- Storage temp. 2-8°C
- pka
- 3.34±0.10(Predicted)
- Aussehen
- Off-white to light yellow Solid
- Optische Rotation
- [α]20/D +102°, c = 1 in THF
- BRN
- 4719761
- Major Application
- peptide synthesis
- InChI
- InChI=1/C15H11N3O7/c19-14(16-13(15(20)21)9-4-2-1-3-5-9)10-6-11(17(22)23)8-12(7-10)18(24)25/h1-8,13H,(H,16,19)(H,20,21)/t13-/s3
- InChIKey
- MIVUDAUOXJDARR-ZDUSSCGKSA-N
- SMILES
- C(C1C=C(N(=O)=O)C=C(N(=O)=O)C=1)(=O)N[C@@H](C1C=CC=CC=1)C(=O)O |&1:15,r|
Sicherheit
| S-S?tze: |
22-24/25 |
|
|
| WGK Germany |
3 |
|
|
| F |
10-21 |
|
|
| Speicherklasse |
11 - Combustible Solids |
|
|
(S)-(+)-N-(3,5-DINITROBENZOYL)-ALPHA-PHENYLGLYCINE Chemische Eigenschaften,Einsatz,Produktion Methoden
S-S?tze Betriebsanweisung:
S22:Staub nicht einatmen.
S24/25:Berührung mit den Augen und der Haut vermeiden.
(S)-(+)-N-(3,5-DINITROBENZOYL)-ALPHA-PHENYLGLYCINE Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
(S)-(+)-N-(3,5-DINITROBENZOYL)-ALPHA-PHENYLGLYCINE Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 75)Lieferanten
90761-62-9()Verwandte Suche:
- (S)-(+)-N-(3,5-DINITROBENZOYL)-ALPHA-PHENYLGLYCINE
- (S)-(+)-N-(3,5-DINITROBENZOYL)PHENYLGLYCINE
- (S)-3,5-DINITRO-BENZOYL-L-PHENYL GLYCINE
- N-(3,5-DINITROBENZOYL)-L-ALPHA-PHENYLGLYCINE
- D-3,5-Dinitrobenzoylleucine
- N-(3,5-DINITROBENZOYL)-S-(+)-A-PHENYLGLY CINE, 95%
- N-(3 5-DINITROBENZOYL)-L-ALPHA-PHENYL- &
- (S)-(+)-N-(3,5-DINITROBENZOYL) PHENYLGLYCINE 98+%
- (b)-(+)-N-(3,5-Dinitrobenzoyl)-alpha-phenylglycine
- Benzeneacetic acid, .alpha.-(3,5-dinitrobenzoyl)amino-, (.alpha.S)-
- n-(3,5-dinitrobenzoyl)-l-α-phenylglycine
- METHYL 2,3-EPOXY-3-(4-METHOXYPHENYL)PROPRONATE
- N-(3,5-Dinitrobenzoyl)-L-α-phenylglycine, S-(+)-N-(3,5-Dinitrobenzoyl)phenylglycine
- (S)-(+)-N-(3,5-DINITROBENZOYL) PHENYLGLY
- (2S)-2-[(3,5-dinitrobenzoyl)amino]-2-phenylacetic acid
- L-3,5-Dinitrobenzoylphe nylglycine
- Benzeneacetic acid, α-[(3,5-dinitrobenzoyl)amino]-, (αS)-
- (S)-(+)-N-(3,5-Dinitrobenzoyl)-α-phenylglycine
- (2S)-2-[(3,5-dinitrobenzoyl)amino]-2-phenylaceticaci
- (S)-(+)-N-(3,5-DINITROBENZOYL)-ALPHA-PHENYLGLYCINE USP/EP/BP
- (S)-(+)-(3,5-Dinitrobenzoyl)-alpha-phenylglycine
- (S)-(+)-N-(3,5-Dinitrobenzoyl)-α-phenylglycine
- 90761-62-9
- Peptide Synthesis
- Phenylglycine Derivatives
- Unnatural Amino Acid Derivatives
- UV-VIS
- Specialty Synthesis
- Intermediate
